Maintaining Suppression of Testosterone With Transdermal Estradiol Gel

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The objective of this clinical study is to evaluate the safety and efficacy of three different doses of BHR-200 (0.36% transdermal estradiol gel) compared to placebo for the maintenance of testosterone (T) suppression in men with advanced androgen-sensitive prostate cancer.
Epistemonikos ID: 2066389f9f6c67bbfd7d015d51fc2745485115b4
First added on: May 12, 2024